Left: ‘I will reveal more in time and will update research.’
NEW YORK: Andrew Left, the short seller who unleashed the storm around Valeant Pharmaceuticals International Inc, is quick to swat away all the good things billionaire William Ackman has to say about stricken drug company.
Ackman, whose Pershing Square Capital Management is one of Valeant’s biggest shareholders, hadn’t even finished his highly-anticipated defence of the company on Friday before Left fired another shot and sent Valeant’s share price tumbling anew.
Already a subscriber? Log in.
Limited time offer:
Just RM5 per month.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
